ENDRA Life Sciences, Inc. (NDRA)
4.80
+0.02
(+0.42%)
USD |
NASDAQ |
Oct 23, 16:00
4.80
0.00 (0.00%)
After-Hours: 20:00
ENDRA Life Sciences Enterprise Value : 2.088M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.088M |
| October 22, 2026 | 2.058M |
| October 21, 2026 | 1.908M |
| October 20, 2026 | 1.594M |
| October 19, 2026 | 2.013M |
| October 16, 2026 | 1.998M |
| October 15, 2026 | 2.538M |
| October 14, 2026 | 2.051M |
| October 13, 2026 | 2.448M |
| October 12, 2026 | 2.591M |
| October 09, 2026 | 3.078M |
| October 08, 2026 | 3.783M |
| October 07, 2026 | 3.978M |
| October 06, 2026 | 3.948M |
| October 05, 2026 | 4.353M |
| October 02, 2026 | 3.978M |
| October 01, 2026 | 3.708M |
| September 30, 2026 | 3.828M |
| September 29, 2026 | 3.708M |
| September 28, 2026 | 3.588M |
| September 25, 2026 | 3.948M |
| September 24, 2026 | 3.783M |
| September 23, 2026 | 4.638M |
| September 22, 2026 | 4.233M |
| September 21, 2026 | 4.353M |
| Date | Value |
|---|---|
| September 18, 2026 | 3.138M |
| September 17, 2026 | 3.016M |
| September 16, 2026 | 2.838M |
| September 15, 2026 | 3.288M |
| September 14, 2026 | 3.693M |
| September 11, 2026 | 3.318M |
| September 10, 2026 | 3.566M |
| September 09, 2026 | 3.633M |
| September 08, 2026 | 3.746M |
| September 04, 2026 | 3.963M |
| September 03, 2026 | 3.408M |
| September 02, 2026 | 4.578M |
| September 01, 2026 | 2.793M |
| August 31, 2026 | 2.396M |
| August 28, 2026 | 2.396M |
| August 27, 2026 | 2.996M |
| August 26, 2026 | 3.048M |
| August 25, 2026 | 2.013M |
| August 24, 2026 | 1.728M |
| August 21, 2026 | 1.624M |
| August 20, 2026 | 1.766M |
| August 19, 2026 | 1.668M |
| August 18, 2026 | 1.654M |
| August 17, 2026 | 1.624M |
| August 14, 2026 | 1.594M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 162.02M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 557.06M |
| ResMed, Inc. | 35.83B |
| Rockwell Medical, Inc. | 16.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.1599M |
| Total Expenses (Quarterly) | -0.1599M |
| EPS Diluted (Quarterly) | 0.1208 |
| Earnings Yield | -131.6% |
| Normalized Earnings Yield | -126.98 |